15,645 Shares in iShares Nasdaq Biotechnology ETF (IBB) Purchased by 1 North Wealth Services LLC

Share on StockTwits

1 North Wealth Services LLC bought a new stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 15,645 shares of the financial services provider’s stock, valued at approximately $1,509,000. iShares Nasdaq Biotechnology ETF makes up 1.3% of 1 North Wealth Services LLC’s holdings, making the stock its 26th largest position.

A number of other institutional investors also recently modified their holdings of IBB. Parkside Financial Bank & Trust bought a new position in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter valued at $29,000. Intercontinental Wealth Advisors LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter valued at $56,000. Schroder Investment Management Group bought a new position in shares of iShares Nasdaq Biotechnology ETF during the second quarter valued at $105,000. Benjamin F. Edwards & Company Inc. raised its stake in shares of iShares Nasdaq Biotechnology ETF by 636.4% during the third quarter. Benjamin F. Edwards & Company Inc. now owns 891 shares of the financial services provider’s stock valued at $109,000 after acquiring an additional 770 shares during the last quarter. Finally, North Star Investment Management Corp. raised its stake in shares of iShares Nasdaq Biotechnology ETF by 21.6% during the fourth quarter. North Star Investment Management Corp. now owns 1,180 shares of the financial services provider’s stock valued at $114,000 after acquiring an additional 210 shares during the last quarter. Hedge funds and other institutional investors own 66.51% of the company’s stock.

Shares of NASDAQ IBB opened at $109.75 on Thursday. iShares Nasdaq Biotechnology ETF has a twelve month low of $89.01 and a twelve month high of $122.97.

WARNING: “15,645 Shares in iShares Nasdaq Biotechnology ETF (IBB) Purchased by 1 North Wealth Services LLC” was first posted by Macon Daily and is owned by of Macon Daily. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://macondaily.com/2019/02/14/15645-shares-in-ishares-nasdaq-biotechnology-etf-ibb-purchased-by-1-north-wealth-services-llc.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What is an Initial Public Offering (IPO)?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply